197 related articles for article (PubMed ID: 10504221)
21. MARCKS, membranes, and calmodulin: kinetics of their interaction.
Arbuzova A; Murray D; McLaughlin S
Biochim Biophys Acta; 1998 Nov; 1376(3):369-79. PubMed ID: 9804991
[TBL] [Abstract][Full Text] [Related]
22. Membrane domains containing phosphatidylserine and substrate can be important for the activation of protein kinase C.
Yang L; Glaser M
Biochemistry; 1995 Feb; 34(5):1500-6. PubMed ID: 7531492
[TBL] [Abstract][Full Text] [Related]
23. Lateral sequestration of phosphatidylinositol 4,5-bisphosphate by the basic effector domain of myristoylated alanine-rich C kinase substrate is due to nonspecific electrostatic interactions.
Wang J; Gambhir A; Hangyás-Mihályné G; Murray D; Golebiewska U; McLaughlin S
J Biol Chem; 2002 Sep; 277(37):34401-12. PubMed ID: 12097325
[TBL] [Abstract][Full Text] [Related]
24. Myristoylated alanine-rich C kinase substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-bisphosphate in lateral domains.
Glaser M; Wanaski S; Buser CA; Boguslavsky V; Rashidzada W; Morris A; Rebecchi M; Scarlata SF; Runnels LW; Prestwich GD; Chen J; Aderem A; Ahn J; McLaughlin S
J Biol Chem; 1996 Oct; 271(42):26187-93. PubMed ID: 8824266
[TBL] [Abstract][Full Text] [Related]
25. Membrane association of the myristoylated alanine-rich C kinase substrate (MARCKS) protein appears to involve myristate-dependent binding in the absence of a myristoyl protein receptor.
George DJ; Blackshear PJ
J Biol Chem; 1992 Dec; 267(34):24879-85. PubMed ID: 1332970
[TBL] [Abstract][Full Text] [Related]
26. Electrostatic sequestration of PIP2 on phospholipid membranes by basic/aromatic regions of proteins.
Gambhir A; Hangyás-Mihályné G; Zaitseva I; Cafiso DS; Wang J; Murray D; Pentyala SN; Smith SO; McLaughlin S
Biophys J; 2004 Apr; 86(4):2188-207. PubMed ID: 15041659
[TBL] [Abstract][Full Text] [Related]
27. The effector domain of myristoylated alanine-rich C kinase substrate binds strongly to phosphatidylinositol 4,5-bisphosphate.
Wang J; Arbuzova A; Hangyás-Mihályné G; McLaughlin S
J Biol Chem; 2001 Feb; 276(7):5012-9. PubMed ID: 11053422
[TBL] [Abstract][Full Text] [Related]
28. Interaction of the effector domain of MARCKS and MARCKS-related protein with lipid membranes revealed by electric potential measurements.
Bähr G; Diederich A; Vergères G; Winterhalter M
Biochemistry; 1998 Nov; 37(46):16252-61. PubMed ID: 9819217
[TBL] [Abstract][Full Text] [Related]
29. Interaction between actin and the effector peptide of MARCKS-related protein. Identification of functional amino acid segments.
Wohnsland F; Schmitz AA; Steinmetz MO; Aebi U; Vergéres G
J Biol Chem; 2000 Jul; 275(27):20873-9. PubMed ID: 10748210
[TBL] [Abstract][Full Text] [Related]
30. Direct involvement of protein myristoylation in myristoylated alanine-rich C kinase substrate (MARCKS)-calmodulin interaction.
Matsubara M; Titani K; Taniguchi H; Hayashi N
J Biol Chem; 2003 Dec; 278(49):48898-902. PubMed ID: 14506265
[TBL] [Abstract][Full Text] [Related]
31. Functional role of the interaction between polysialic acid and myristoylated alanine-rich C kinase substrate at the plasma membrane.
Theis T; Mishra B; von der Ohe M; Loers G; Prondzynski M; Pless O; Blackshear PJ; Schachner M; Kleene R
J Biol Chem; 2013 Mar; 288(9):6726-42. PubMed ID: 23329829
[TBL] [Abstract][Full Text] [Related]
32. Solution and membrane bound structure of a peptide derived from the protein kinase C substrate domain of neuromodulin.
Wertz SL; Savino Y; Cafiso DS
Biochemistry; 1996 Aug; 35(34):11104-12. PubMed ID: 8780514
[TBL] [Abstract][Full Text] [Related]
33. Myristoylation-dependent N-terminal cleavage of the myristoylated alanine-rich C kinase substrate (MARCKS) by cellular extracts.
Braun T; McIlhinney RA; Vergères G
Biochimie; 2000 Aug; 82(8):705-15. PubMed ID: 11018286
[TBL] [Abstract][Full Text] [Related]
34. Phosphatidylserine specific binding protein in rat brain: purification and characterization.
Nakaoka T; Kojima N; Hamamoto T; Kurosawa N; Lee YC; Kawasaki H; Suzuki K; Tsuji S
J Biochem; 1993 Oct; 114(4):449-52. PubMed ID: 8276751
[TBL] [Abstract][Full Text] [Related]
35. Determinants of Curvature-Sensing Behavior for MARCKS-Fragment Peptides.
de Jesus AJ; White OR; Flynn AD; Yin H
Biophys J; 2016 May; 110(9):1980-92. PubMed ID: 27166806
[TBL] [Abstract][Full Text] [Related]
36. Reversible - through calmodulin - electrostatic interactions between basic residues on proteins and acidic lipids in the plasma membrane.
McLaughlin S; Hangyás-Mihályné G; Zaitseva I; Golebiewska U
Biochem Soc Symp; 2005; (72):189-98. PubMed ID: 15649142
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation-dependent conformational changes induce a switch in the actin-binding function of MARCKS.
Bubb MR; Lenox RH; Edison AS
J Biol Chem; 1999 Dec; 274(51):36472-8. PubMed ID: 10593944
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of native and recombinant nicotinic acetylcholine receptors by the myristoylated alanine-rich C kinase substrate peptide.
Gay EA; Klein RC; Melton MA; Blackshear PJ; Yakel JL
J Pharmacol Exp Ther; 2008 Dec; 327(3):884-90. PubMed ID: 18812491
[TBL] [Abstract][Full Text] [Related]
39. Actin filament cross-linking by MARCKS: characterization of two actin-binding sites within the phosphorylation site domain.
Yarmola EG; Edison AS; Lenox RH; Bubb MR
J Biol Chem; 2001 Jun; 276(25):22351-8. PubMed ID: 11294839
[TBL] [Abstract][Full Text] [Related]
40. Cross-talk unfolded: MARCKS proteins.
Arbuzova A; Schmitz AA; Vergères G
Biochem J; 2002 Feb; 362(Pt 1):1-12. PubMed ID: 11829734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
